Electromagnetic pulse transparency in coupled cavity arrays through dispersion management

We theoretically demonstrated the possible emergence of slow-light self-induced transparency solitons in the infinite one-dimensional coupled cavity array, with each cavity containing a single qubit. We have predicted a substantial dependence of pulse transparency on its dimensionless width $\tau_0$. In particular, short pulses whose widths range from $\tau_0\ll 1$ to $\tau_0\lesssim 1$ exhibit simple, almost linear dispersion law with a finite frequency gap of the order of the cavity array photonic band gap. That is, the medium is opaque for very short pulses with carrier wave frequency below the photonic gap. When the pulse width exceeds the critical one, a twin transparency window separated by a finite band gap appears in the soliton pulse dispersion law. Observation of predicted effects within the proposed setup would be of interest for understanding the properties of self-induced transparency effect in general and future applications in the design of quantum technological devices

On the influence of the "donor"/"acceptor" presence on the excitation states in molecular chains: non-adiabatic polaron approach

In the paper, we considered a molecular structure that consists of a molecular chain and an additional molecule ("donor"/"acceptor") that can inject (or remove) single excitation (vibron, electron, e.t.c.) onto the molecular chain. We assumed that the excitation forms a self-trapped state due to the interaction with mechanical oscillations of chain structure elements. We analyzed the energy spectra of the excitation and showed that its state (when it migrates to the molecular chain) has the properties of the non-adiabatic polaron state. The conditions under which the excitation can migrate from one subsystem to another were considered. It was shown that the presence of a "donor" molecule cannot significantly change the properties of the excitation located on the molecular chain. At the same time, the molecular chain can affect the position of the energy level of the excitation localized on the "donor" subsystem. Indirectly, this can influence the process of excitation migration from one subsystem to another one. The influence of basic energy parameters of the system and the environment temperature on this process are discussed. The entire system was assumed to be in thermal equilibrium with the environment

Classification in biological networks with hypergraphlet kernels

MOTIVATION: Biological and cellular systems are often modeled as graphs in which vertices represent objects of interest (genes, proteins and drugs) and edges represent relational ties between these objects (binds-to, interacts-with and regulates). This approach has been highly successful owing to the theory, methodology and software that support analysis and learning on graphs. Graphs, however, suffer from information loss when modeling physical systems due to their inability to accurately represent multiobject relationships. Hypergraphs, a generalization of graphs, provide a framework to mitigate information loss and unify disparate graph-based methodologies. RESULTS: We present a hypergraph-based approach for modeling biological systems and formulate vertex classification, edge classification and link prediction problems on (hyper)graphs as instances of vertex classification on (extended, dual) hypergraphs. We then introduce a novel kernel method on vertex- and edge-labeled (colored) hypergraphs for analysis and learning. The method is based on exact and inexact (via hypergraph edit distances) enumeration of hypergraphlets; i.e. small hypergraphs rooted at a vertex of interest. We empirically evaluate this method on fifteen biological networks and show its potential use in a positive-unlabeled setting to estimate the interactome sizes in various species. AVAILABILITY AND IMPLEMENTATION: https://github.com/jlugomar/hypergraphlet-kernels. SUPPLEMENTARY INFORMATION: Supplementary data are available at Bioinformatics online

Cancer-related health behaviours of young people not in education, employment or training ('NEET'): a cross-sectional study

This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were madeThis study was funded by Cancer Research UK (C53258/A19682) and the Medical Research Council/ Chief Scientist Office Social & Public Health Sciences Unit, University of Glasgow under the Measuring and Analysing Socioeconomic Inequalities in Health programme (MC_UU_12017/13 & SPHSU13)

Kartierung der Zwergrostresistenz der Gerste MBR1012

Zusammenfassung Der Zwergrost gehört zu den wichtigsten Krankheitserregern der Gerste und kann im gemäßigten Klima Ertragsverluste von über 60 % verursachen. Auf der Suche nach neuen Resistenzquellen wurde in der aus Serbien-Montenegro stammenden Landrasse MBR1012 eine wirksame Resistenz gegenüber Zwergrost identifiziert. Um die Vererbung der Resistenz dieser Landrasse aufzuklären, wurden 76 DH-Linien aus der Kreuzung der resistenten Landrasse MBR1012 mit der anfälligen Sorte Scarlett mit der hochvirulenten Zwergrostrasse I80 künstlich inokuliert. Die Spaltung der DH-Population nach der Inokulation mit I80 zeigte, dass die Resistenz monogenetisch vererbt wird. Basierend auf den Ergebnissen der bulked segregant analysis konnte die Resistenz dem Chromosom 1H zugeordnet werden und eng gekoppelte molekulare Marker entwickelt werden, welche eine beschleunigte Übertragung dieser Resistenz in adaptierte Sorten erlauben. Die Suche nach neuen Resistenzen gegen Puccinia hordei ist von besonderer Bedeutung, da die Rostpilze durch Mutation und Rekombination zahlreiche physiologische Rassen bilden, wodurch Resistenzen relativ schnell überwunden werden können. Stichwörter: Gerste (Hordeum vulgare L.), Zwergrost (Puccinia hordei Otth), Resistenz, bulked segregant analysis (BSA), DH-Linien (doubled-haploid).   Abstract Leaf rust (Puccinia hordei Otth) is an economically important disease of barley in temperate regions, causing considerable yield losses up to about 60 %. Resistance to leaf rust has been detected in a landrace derived from Serbia Montenegro (MBR1012). To obtain information on the genetics of resistance of MBR1012 to leaf rust, 76 DH-lines derived from a cross of MBR1012 to the susceptible cv. Scarlett were inoculated using the highly virulent leaf rust isolate I80. It turned out that resistance is inherited in a monogenic manner and by bulked segregant analysis resistance was assigned to chromosome 1H. Next closely linked molecular markers were developed facilitating an efficient introgression into adapted cultivars. Broadening the genetic base of resistance to leaf rust is of special importance as this pathogen is able to overcome resistances quickly due to mutation and recombination. Keywords: Barley (Hordeum vulgare L.), leaf rust (Puccinia hordei Otth), resistance, bulked segregant analysis (BSA), DH-lines (doubled-haploid

Antiproliferative activity and mode of action analysis of novel amino and amido substituted phenantrene and naphtho[2,1-b]thiophene derivatives

Herein we present and describe the design and synthesis of novel phenantrene derivatives substituted with either amino or amido side chains and their biological activity. Antiproliferative activities were assessed in vitro on a panel of human cancer cell lines. Tested compounds showed moderate activity against cancer cells in comparison with 5-fluorouracile. Among all tested compounds, some compounds substituted with cyano groups showed a pronounced and selective activity in the nanomolar range of inhibitory concentrations against HeLa and HepG2. The strongest selective activity against HeLa cells was observed for acrylonitriles 8 and 11 and their cyclic analogues 15 and 17 substituted with two cyano groups with a corresponding IC50 = 0.33, 0.21, 0.65 and 0.45 μM, respectively. Compounds 11 showed the most pronounced selectivity being almost non cytotoxic to normal fibroblasts. Additionally, mode of biological action analysis was performed in silico and in vitro by Western blot analysis of HIF-1-α relative expression for compounds 8 and 11

A Randomized Trial of E-Cigarettes versus Nicotine-Replacement Therapy

BACKGROUND: E-cigarettes are commonly used in attempts to stop smoking, but evidence is limited regarding their effectiveness as compared with that of nicotine products approved as smoking-cessation treatments. METHODS: We randomly assigned adults attending U.K. National Health Service stop-smoking services to either nicotine-replacement products of their choice, including product combinations, provided for up to 3 months, or an e-cigarette starter pack (a second-generation refillable e-cigarette with one bottle of nicotine e-liquid [18 mg per milliliter]), with a recommendation to purchase further e-liquids of the flavor and strength of their choice. Treatment included weekly behavioral support for at least 4 weeks. The primary outcome was sustained abstinence for 1 year, which was validated biochemically at the final visit. Participants who were lost to follow-up or did not provide biochemical validation were considered to not be abstinent. Secondary outcomes included participant-reported treatment usage and respiratory symptoms. RESULTS: A total of 886 participants underwent randomization. The 1-year abstinence rate was 18.0% in the e-cigarette group, as compared with 9.9% in the nicotine-replacement group (relative risk, 1.83; 95% confidence interval [CI], 1.30 to 2.58; P<0.001). Among participants with 1-year abstinence, those in the e-cigarette group were more likely than those in the nicotine-replacement group to use their assigned product at 52 weeks (80% [63 of 79 participants] vs. 9% [4 of 44 participants]). Overall, throat or mouth irritation was reported more frequently in the e-cigarette group (65.3%, vs. 51.2% in the nicotine-replacement group) and nausea more frequently in the nicotine-replacement group (37.9%, vs. 31.3% in the e-cigarette group). The e-cigarette group reported greater declines in the incidence of cough and phlegm production from baseline to 52 weeks than did the nicotine-replacement group (relative risk for cough, 0.8; 95% CI, 0.6 to 0.9; relative risk for phlegm, 0.7; 95% CI, 0.6 to 0.9). There were no significant between-group differences in the incidence of wheezing or shortness of breath. CONCLUSIONS: E-cigarettes were more effective for smoking cessation than nicotine-replacement therapy, when both products were accompanied by behavioral support. (Funded by the National Institute for Health Research and Cancer Research UK; Current Controlled Trials number, ISRCTN60477608 .)

E-cigarettes compared with nicotine replacement therapy within the UK Stop Smoking Services : the TEC RCT

© Queen’s Printer and Controller of HMSO 2019. Background: Over the past few years, a large number of smokers in the UK have stopped smoking with the help of e-cigarettes. So far, UK Stop Smoking Services (SSSs) have been reluctant to include e-cigarettes among their treatment options because data on their efficacy compared with the licensed medications are lacking. Objective: The objective was to compare the efficacy of refillable e-cigarettes and nicotine replacement therapy (NRT) products, when accompanied by weekly behavioural support. Design: A randomised controlled trial comparing e-cigarettes and NRT. Setting: Three sites that provide local SSSs. Participants: The participants were 886 smokers seeking help to quit smoking, aged ≥ 18 years, not pregnant or breastfeeding, with no strong preference to use or not to use NRT or e-cigarettes in their quit attempt, and currently not using NRT or e-cigarettes. A total of 886 participants were randomised but two died during the study (one in each study arm) and were not included in the analysis. Interventions: The NRT arm (n = 446) received NRT of their choice (single or combination), provided for up to 12 weeks. The e-cigarette arm (n = 438) received an e-cigarette starter pack and were encouraged to buy addtional e-liquids and e-cigarette products of their choice. Both arms received the same standard behavioural support. Participants attended weekly sessions at their SSS and provided outcome data at 4 weeks. They were then followed up by telephone at 6 and 12 months. Participants reporting abstinence or at least 50% reduction in cigarette consumption at 12 months were invited to attend for carbon monoxide (CO) validation. Participants/ researchers could not be blinded to the intervention.Main outcome measures: The primary outcome was CO-validated sustained abstinence rates at 52 weeks. Participants lost to follow-up or not providing biochemical validation were included as non-abstainers. Secondary outcomes included abstinence at other time points, reduction in smoke intake, treatment adherence and ratings, elicited adverse reactions, and changes in self-reported respiratory health. A cost-efficacy analysis of the intervention was also conducted. Results: The 1-year quit rate was 9.9% in the NRT arm and 18.0% in the e-cigarette arm (risk ratio 1.83, 95% confidence interval 1.30 to 2.58; p < 0.001). The e-cigarette arm had significantly higher validated quit rates at all time points. Participants in the e-cigarette arm showed significantly better adherence and experienced fewer urges to smoke throughout the initial 4 weeks of their quit attempt than those in the NRT arm, and gave their allocated product more favourable ratings. They were also more likely to be still using their allocated product at 1 year (39.5% vs. 4.3%, Χ2 = 161.4; p < 0.001). Participants assigned to e-cigarettes reported significantly less coughing and phlegm at 1 year than those assigned to NRT (controlling for smoking status). A detailed economic analysis confirmed that, because e-cigarettes incur lower NHS costs than NRT and generate a higher quit rate, e-cigarette use is more cost-effective. Limitations: The results may not be generalisable to other types of smokers or settings, or to cartridge-based e-cigarettes. Conclusions: Within the context of multisession treatment for smokers seeking help, e-cigarettes were significantly more effective than NRT. If SSSs provide e-cigarette starter packs, it is likely to boost their success rates and improve their cost-efficacy

A Qualitative Study of Factors Influencing Adherence among Pregnant Women Taking Part in a Trial of E-Cigarettes for Smoking Cessation.

Use of e-cigarettes (vaping) has potential to help pregnant women stop smoking. This study explored factors influencing adherence among participants in the vaping arm of the first trial of vaping for smoking cessation in pregnancy. We conducted semi-structured telephone interviews (n = 28) with women at three-months postpartum. Interviews were analysed using thematic analysis, informed by the Theoretical-Domains Framework, Necessity-Concerns Framework and Perceptions and Practicalities Approach. Interviewees generally reported high levels of vaping. We found that: (1) intervention adherence was driven by four necessity beliefs-stopping smoking for the baby, and vaping for harm reduction, smoking cessation or as a last resort; (2) necessity beliefs outweighed vaping concerns, such as dependence and safety; (3) adherence was linked to four practicalities themes, acting as barriers and facilitators to vaping-device and e-liquid perceptions, resources and support, whether vaping became habitual, and social and environmental factors; and (4) intentional non-adherence was rare; unintentional non-adherence was due to device failures, forgetting to vape, and personal circumstances and stress. Pregnant smokers provided with e-cigarettes, and with generally high levels of vaping, had positive beliefs about the necessity of vaping for smoking cessation which outweighed concerns about vaping. Non-adherence was mainly due to unintentional factors